A Psychiatrist Crusades To Bring Risk Taking To Canadian Science

The ex-chairman of the nation’s Science Council forms a startup to spark government scientists OTTAWA—Stuart L Smith was fed up with his government’s inability to help Canadian scientists turn their knowledge into commercial products. So he formed his own company to do something about it. A psychiatrist turned liberal politician, Smith served from 1982 to 1987 as chairman of the Science Council of Canada. The council, Canada’s equivalent to the National Academy of S

Written byDavid Spurgeon
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

The ex-chairman of the nation’s Science Council forms a startup to spark government scientists

OTTAWA—Stuart L Smith was fed up with his government’s inability to help Canadian scientists turn their knowledge into commercial products. So he formed his own company to do something about it.

A psychiatrist turned liberal politician, Smith served from 1982 to 1987 as chairman of the Science Council of Canada. The council, Canada’s equivalent to the National Academy of Sciences, provides the government with a stream of reports on science and technology policy issues. In his capacity, Smith saw what he calls “an abominable waste of research talent.”

His favorite example is the case of two government scientists who discovered a method of extracting oil from sewage sludge. Not only would their process permit the oil to be used, but it would also make the sludge safe enough to be buried as landfill. Yet nobody in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies